RxSight

RXSIGHT INC

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

Medicine,Development,Laboratory:,Caucasian,Female,Scientist,Using,Microscope,,Analyzes,Petri

Analyst Color

Downgrades

Health Care

Price Target

Analyst Ratings

General

RXST

RxSight revised its FY25 revenue outlook below estimates, with Q1 sales lagging expectations. BofA downgraded the stock, citing slowing growth and risks ahead.

RxSight Analyst Flags Growth Slowdown As Revised Outlook Misses Expectations

Wall Street_Dow

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ALDX

AREB

NIVF

PTIX

TIVC

Dow Tumbles Over 1,100 Points; US Initial Jobless Claims Fall

Apple TV+Losing Over $1 Billion Yearly- Report

Pre-Market Outlook

Movers

AAPL

ASIX

CCNE

LULU

NVDA

THRY

TSLA

RH Posts Downbeat Earnings, Joins Apple, Tesla, Nvidia And Other Big Stocks Moving Lower In Thursday&#39;s Pre-Market Session

RxSight Inc

Press Releases

RxSight, Inc. Reports Second Quarter 2024 Financial Results

RxSight, Inc. to Participate in Upcoming Morgan Stanley and Wells Fargo Healthcare Conferences

RxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024

RxSight, Inc. Reports Third Quarter 2024 Financial Results

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance

RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025

RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance

RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance

Advanced Biomed

Align Technology

Avanos Medical

Bioventus

Cerus

The Cooper Companies, Inc. - Common Stock

Cooper Companies

Embecta

Establishment Labs Holdings Inc. - Common Shares

Establishment Labs Hldgs

Haemonetics

ICU Medical

OrthoPediatrics

Lantheus Holdings

Merit Medical Systems, Inc. - Common Stock

Merit Medical Systems

Neogen

InspireMD

OraSure Technologies, Inc. - Common Stock

OraSure Technologies

Sanara MedTech

Solventum

Staar Surgical

TELA Bio

UFP Technologies

Utah Medical Products, Inc. - Common Stock

Utah Medical Products

VolitionRX

Dentsply Sirona

Xtant Medical Holdings, Inc. Common Stock

Xtant Medical Hldgs

JP Morgan

Wells Fargo

Needham

B of A Securities

Stifel

Comments

RxSight

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga